共 200 条
- [31] Rawat D(2022)Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial Lancet Gastroenterol Hepatol 7 830-1515
- [32] Alam S(2020)A systematic review of patient-reported outcomes in primary biliary cholangitis and primary sclerosing cholangitis Hepatol Commun 4 1502-95
- [33] Kremer AE(2020)Newer approaches to the management of pruritus in cholestatic liver disease Curr Hepatol Rep 19 86-514
- [34] Oude Elferink RP(2013)Pruritus assessment in clinical trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials Acta Derm Venereol 93 509-1121
- [35] Beuers U(2011)Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe Allergy 66 1114-202
- [36] Mehl A(2021)Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: phase 2 study Clin Res Hepatol Gastroenterol 45 199-447
- [37] Bohorquez H(2021)Evaluation of the role of bile acids and serotonin as markers of pruritus in children with chronic cholestatic liver disease Arab J Gastroenterol 22 442-1198
- [38] Serrano MS(1999)Use of rifampin for severe pruritus in children with chronic cholestasis J Pediatr Gastroenterol Nutr 29 1184-82
- [39] Galliano G(2018)Placebo-controlled randomized trial of an intestinal bile salt transport inhibitor for pruritus in Alagille syndrome Hepatol Commun 2 69-479
- [40] Reichman TW(2018)Development of a novel tool to assess the impact of itching in pediatric cholestasis Patient 11 461-undefined